Table Filtering
Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
GlycoNAVI Proteins
GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
| Source | Last Updated |
|---|---|
| GlycoNAVI Proteins | September 04, 2024 |
| PDB ID | UniProt ID | Title ▲ | Descriptor |
|---|---|---|---|
| 1O70 | P10674 | Novel Fold Revealed by the Structure of a FAS1 Domain Pair from the Insect Cell Adhesion Molecule Fasciclin I | FASCICLIN I |
| 5M7M | Q13822 | Novel Imidazo[1,2-a]pyridine Derivatives with Potent Autotaxin/ENPP2 Inhibitor Activity | Ectonucleotide pyrophosphatase/phosphodiesterase family member 2 (E.C.3.1.4.39) |
| 5MHP | Q13822 | Novel Imidazo[1,2-a]pyridine Derivatives with Potent Autotaxin/ENPP2 Inhibitor Activity | |
| 2XYW | Q03181 | Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Activated Receptor (PPAR) gamma-delta Agonists with High Potency and In-vivo Efficacy | |
| 2XYX | Q03181 | Novel Sulfonylthiadiazoles with an Unusual Binding Mode as Partial Dual Peroxisome Proliferator-Activated Receptor (PPAR) gamma-delta Agonists with High Potency and In-vivo Efficacy | |
| 3EFX | 3EFX | Novel binding site identified in a hybrid between cholera toxin and heat-labile enterotoxin, 1.9A crystal structure reveals the details | |
| 5C92 | E3QHV8 | Novel fungal alcohol oxidase with catalytic diversity among the AA5 family, in complex with copper | |
| 6BRB | P29965 | Novel non-antibody protein scaffold targeting CD40L | |
| 6BRB | 6BRB | Novel non-antibody protein scaffold targeting CD40L | |
| 2WLQ | Q874E3 | Nucleophile-disabled Lam16A mutant holds laminariheptaose (L7) in a cyclical conformation | |
| 8QC0 | K9TVX3 | Nucleoside 2'deoxyribosyltransferase from Chroococcidiopsis thermalis PCC 7203 WT ribosylated | |
| 4BGA | Q8TX37 | Nucleotide-bound open form of a putative sugar kinase MK0840 from Methanopyrus kandleri | |
| 1VXR | P04058 | O-ETHYLMETHYLPHOSPHONYLATED ACETYLCHOLINESTERASE OBTAINED BY REACTION WITH O-ETHYL-S-[2-[BIS(1-METHYLETHYL)AMINO]ETHYL] METHYLPHOSPHONOTHIOATE (VX) | |
| 3WV0 | C9JGG1 | O-glycan attached to herpes simplex virus type 1 glycoprotein gB is recognized by the Ig V-set domain of human paired immunoglobulin-like type 2 receptor alpha | |
| 3WV0 | P06437 | O-glycan attached to herpes simplex virus type 1 glycoprotein gB is recognized by the Ig V-set domain of human paired immunoglobulin-like type 2 receptor alpha | |
| 7LA8 | 7LA8 | O6 variable lymphocyte receptor ectodomain bound to 3-HSO3-Gal-4GlcNAc | |
| 2HHX | Q04957 | O6-methyl-guanine in the polymerase template preinsertion site | |
| 2HHQ | Q5KWC1 | O6-methyl-guanine:T pair in the polymerase-10 basepair position | |
| 2HHS | Q5KWC1 | O6-methyl:C pair in the polymerase-10 basepair position | |
| 1DID | P12070 | OBSERVATIONS OF REACTION INTERMEDIATES AND THE MECHANISM OF ALDOSE-KETOSE INTERCONVERSION BY D-XYLOSE ISOMERASE | |
| 8TZU | P36334 | OC43 S1b domain in complex with WNb 293 and WNb 317 | |
| 8TZU | 8TZU | OC43 S1b domain in complex with WNb 293 and WNb 317 | |
| 1AHP | P00490 | OLIGOSACCHARIDE SUBSTRATE BINDING IN ESCHERICHIA COLI MALTODEXTRIN PHSPHORYLASE | |
| 7ZR9 | P10104 | OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN | |
| 7ZR9 | P0DTC2 | OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN | |
| 7ZR9 | 7ZR9 | OMI-2 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN | |
| 7ZRC | P10104 | OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE | |
| 7ZRC | P0DTC2 | OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE | |
| 7ZRC | 7ZRC | OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE | |
| 7ZR8 | P10104 | OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement) | |
| 7ZR8 | P0DTC2 | OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement) | |
| 7ZR8 | 7ZR8 | OMI-38 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE RBD (local refinement) | |
| 7ZR7 | P10104 | OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN | |
| 7ZR7 | P0DTC2 | OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN | |
| 7ZR7 | 7ZR7 | OMI-42 FAB IN COMPLEX WITH SARS-COV-2 BETA SPIKE GLYCOPROTEIN | |
| 6H03 | P01031 | OPEN CONFORMATION OF THE MEMBRANE ATTACK COMPLEX | COMPLEMENT C5,COMPLEMENT C5, COMPLEMENT COMPONENT C6, COMPLEMENT COMPONENT C8 BETA CHAIN, COMPLEMENT COMPONENT C7, COMPLEMENT COMPONENT C8 GAMMA CHAIN, COMPLEMENT COMPONENT C8 ALPHA CHAIN, COMPLEMENT COMPONENT C9 |
| 6H03 | P13671 | OPEN CONFORMATION OF THE MEMBRANE ATTACK COMPLEX | COMPLEMENT C5,COMPLEMENT C5, COMPLEMENT COMPONENT C6, COMPLEMENT COMPONENT C8 BETA CHAIN, COMPLEMENT COMPONENT C7, COMPLEMENT COMPONENT C8 GAMMA CHAIN, COMPLEMENT COMPONENT C8 ALPHA CHAIN, COMPLEMENT COMPONENT C9 |
| 6H03 | P07358 | OPEN CONFORMATION OF THE MEMBRANE ATTACK COMPLEX | COMPLEMENT C5,COMPLEMENT C5, COMPLEMENT COMPONENT C6, COMPLEMENT COMPONENT C8 BETA CHAIN, COMPLEMENT COMPONENT C7, COMPLEMENT COMPONENT C8 GAMMA CHAIN, COMPLEMENT COMPONENT C8 ALPHA CHAIN, COMPLEMENT COMPONENT C9 |
| 6H03 | P10643 | OPEN CONFORMATION OF THE MEMBRANE ATTACK COMPLEX | COMPLEMENT C5,COMPLEMENT C5, COMPLEMENT COMPONENT C6, COMPLEMENT COMPONENT C8 BETA CHAIN, COMPLEMENT COMPONENT C7, COMPLEMENT COMPONENT C8 GAMMA CHAIN, COMPLEMENT COMPONENT C8 ALPHA CHAIN, COMPLEMENT COMPONENT C9 |
| 6H03 | P07360 | OPEN CONFORMATION OF THE MEMBRANE ATTACK COMPLEX | COMPLEMENT C5,COMPLEMENT C5, COMPLEMENT COMPONENT C6, COMPLEMENT COMPONENT C8 BETA CHAIN, COMPLEMENT COMPONENT C7, COMPLEMENT COMPONENT C8 GAMMA CHAIN, COMPLEMENT COMPONENT C8 ALPHA CHAIN, COMPLEMENT COMPONENT C9 |
| 6H03 | P07357 | OPEN CONFORMATION OF THE MEMBRANE ATTACK COMPLEX | COMPLEMENT C5,COMPLEMENT C5, COMPLEMENT COMPONENT C6, COMPLEMENT COMPONENT C8 BETA CHAIN, COMPLEMENT COMPONENT C7, COMPLEMENT COMPONENT C8 GAMMA CHAIN, COMPLEMENT COMPONENT C8 ALPHA CHAIN, COMPLEMENT COMPONENT C9 |
| 6H03 | P02748 | OPEN CONFORMATION OF THE MEMBRANE ATTACK COMPLEX | COMPLEMENT C5,COMPLEMENT C5, COMPLEMENT COMPONENT C6, COMPLEMENT COMPONENT C8 BETA CHAIN, COMPLEMENT COMPONENT C7, COMPLEMENT COMPONENT C8 GAMMA CHAIN, COMPLEMENT COMPONENT C8 ALPHA CHAIN, COMPLEMENT COMPONENT C9 |
| 1QD5 | P0A921 | OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI | |
| 1IM0 | P0A921 | OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI N156A ACTIVE SITE MUTANT PH 8.3 | |
| 1ILD | P0A921 | OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI N156A ACTIVE SITE MUTANT pH 4.6 | |
| 1ILZ | P0A921 | OUTER MEMBRANE PHOSPHOLIPASE A FROM ESCHERICHIA COLI N156A ACTIVE SITE MUTANT pH 6.1 | |
| 1EBV | P05979 | OVINE PGHS-1 COMPLEXED WITH SALICYL HYDROXAMIC ACID | OVINE PGHS-1 COMPLEXED WITH SALICYL HYDROXAMIC ACID (E.C.1.14.99.1) |
| 5TG4 | Q8RLA6 | OXA-24/40 in Complex with Boronic Acid BA16 | |
| 5FTT | F1LW30 | Octameric complex of Latrophilin 3 (Lec, Olf) , Unc5D (Ig, Ig2, TSP1) and FLRT2 (LRR) | NETRIN RECEPTOR UNC5D, LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN FLRT2, ADHESION G PROTEIN-COUPLED RECEPTOR L3 |
| 5FTT | Q8BLU0 | Octameric complex of Latrophilin 3 (Lec, Olf) , Unc5D (Ig, Ig2, TSP1) and FLRT2 (LRR) | NETRIN RECEPTOR UNC5D, LEUCINE-RICH REPEAT TRANSMEMBRANE PROTEIN FLRT2, ADHESION G PROTEIN-COUPLED RECEPTOR L3 |
